Literature DB >> 10726407

[Prevalence of antibodies to hepatitis A, hepatitis B and hepatitis C viruses in the German population].

W Thierfelder1, H Meisel, E Schreier, R Dortschy.   

Abstract

Representative random samples were tested for hepatitis A, hepatitis B and hepatitis C infections within the framework of the German National Health Interview and Examination Survey. The laboratory parameters included determination of anti-HAV, anti-HBc, anti-HBs, HbsAg, anti-HCV and hepatitis C virus RNA. The prevalence rate for anti-HAV was 46.5% with a definite age-dependence. The infection rates for hepatitis B of 7.7% in former West Germany and of 4.3% in former East Germany were obtained. This is equivalent to a total of 7% prevalence rate. The HbsAg carrier rate was 0.6%. Hepatitis C virus antibodies showed a prevalence rate of 0.4%.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10726407

Source DB:  PubMed          Journal:  Gesundheitswesen        ISSN： 0941-3790


  5 in total

1.  Seroprevalence of hepatitis B and C in subjects admitted to a cardiology clinics in Turkey.

Authors:  O Ozdemir; K Arda; M Soylu; O Alyan; A D Demir; E Kütük
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

2.  Epidemiological Data - an Important Part of the Hemovigilance System.

Authors:  Ruth Offergeld; Osamah Hamouda; Reinhard Burger
Journal:  Transfus Med Hemother       Date:  2010-05-20       Impact factor: 3.747

3.  No influence of atopic diseases on antibody titres following tetanus, diphtheria and hepatitis B immunisation among adults.

Authors:  N Friedrich; A Kramer; R Mentel; L Gürtler; U John; H Völzke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12       Impact factor: 3.267

4.  [HCV, HBV and HIV infections: risk for surgeon and staff. Results and consequences of routine screening in emergency patients].

Authors:  K Dresing; C Pouwels; S Bonsack; M Oellerich; H Schwörer; A Uy; K M Stürmer
Journal:  Chirurg       Date:  2003-11       Impact factor: 0.955

5.  Transplantation of Renal Allografts From Organ Donors Reactive for HCV Antibodies to HCV-Negative Recipients: Safety and Clinical Outcome.

Authors:  Knut Michael Nowak; Oliver Witzke; Georgios C Sotiropoulos; Tamas Benkö; Melanie Fiedler; Jörg Timm; Andreas Kribben; Benjamin Wilde; Fuat Saner; Andreas Paul; Jürgen Treckmann
Journal:  Kidney Int Rep       Date:  2016-10-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.